SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robert Perissi who wrote (336)8/29/1996 9:00:00 AM
From: WWS   of 4342
 
Bob, the five most impressive things about the call were: 1) effectiveness of p355 in initial clincal trails, 2) no toxic side effects for p355, 3) combining other substances w/355 to decrease possibility of HIV's adapting to any one, 4) the possibility that some combination could be brought to market in as little as 9 MONTHS, AS A NUTRITIONAL SUPPLEMENT and 5) at a cost only 1/10 as much as current combinatorial compounds. Bill in St. Louis.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News